0000892917-13-000028.txt : 20130925 0000892917-13-000028.hdr.sgml : 20130925 20130925171858 ACCESSION NUMBER: 0000892917-13-000028 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20130925 DATE AS OF CHANGE: 20130925 EFFECTIVENESS DATE: 20130925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTODYN INC CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: CO FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-203556 FILM NUMBER: 131115129 BUSINESS ADDRESS: STREET 1: 5 CENTERPOINTE DRIVE, SUITE 400 CITY: LAKE OSWEGO STATE: OR ZIP: 97035 BUSINESS PHONE: 971-2040382 MAIL ADDRESS: STREET 1: 5 CENTERPOINTE DRIVE, SUITE 400 CITY: LAKE OSWEGO STATE: OR ZIP: 97035 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D 1 primary_doc.xml X0707 D LIVE 0001175680 CYTODYN INC 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR OREGON 97035 971-204-0382 COLORADO REXRAY CORP Corporation true Nadar Pourhassan 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Executive Officer Director Michael Mulholland 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Executive Officer Jordan Naydenov 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Director Anthony Caracciolo 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Director Gregory Gould 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Director Michael Nobel 5 Centerpointe Drive, Suite 400 Lake Oswego OR OREGON 97035 Director Biotechnology No Revenues 06b false 2013-09-25 false true true true false 0 Paulson Investment Company, Inc. 5670 None None 1331 NW Lovejoy Suite 720 Portland OR OREGON 97209-2897 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA SD SOUTH DAKOTA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false 10010000 3207260 6802740 false 56 1301300 true 0 Represents a 10% cash fee and a 3% non-accountable, administrative fee on gross proceeds assuming the offering is fully sold, plus a warrant to purchase appx 3,465,000 common shares. In addition, a 6% cash fee applies to exercises of investor warrants. 650000 true Represents compensation paid or payable to directors and executive officers in the ordinary course of business. false CYTODYN INC Michael D. Mulholland Michael D. Mulholland Chief Financial Officer, Treasurer and Secretary 2013-09-25